Novo Nordisk Foundation Cellerator

Novo Nordisk Foundation CelleratorNovo Nordisk Foundation Cellerator
Novo Nordisk Foundation Cellerator

Novo Nordisk Foundation Cellerator

A state-of-the-art facility accelerating cell therapies from research to clinical trials for chronic diseases.

Accelerator$136.0M AUMLyngby, Denmark

About

Novo Nordisk Foundation Cellerator is a facility dedicated to advancing the cell therapy ecosystem by providing end-to-end support for the development and manufacturing of cell therapies. It aims to bridge the gap between scientific innovation and patient access by enabling the translation of promising research into real-world treatments for chronic and life-threatening diseases. The facility offers services from process development and GMP manufacturing to regulatory support for early clinical trials.
Frequently asked

What type of investor is Novo Nordisk Foundation Cellerator?

Novo Nordisk Foundation Cellerator is a facility dedicated to advancing the cell therapy ecosystem by providing end-to-end support for the development and manufacturing of cell therapies. It aims to bridge the gap between scientific innovation and patient access by enabling the translation of promising research into real-world treatments for chronic and life-threatening diseases. The facility offe…

What kind of firm is Novo Nordisk Foundation Cellerator?

Novo Nordisk Foundation Cellerator is a Accelerator.

What is Novo Nordisk Foundation Cellerator's assets under management?

Novo Nordisk Foundation Cellerator manages approximately $136M in assets.

Where is Novo Nordisk Foundation Cellerator based?

Novo Nordisk Foundation Cellerator is based in Lyngby, Denmark.

What sectors does Novo Nordisk Foundation Cellerator focus on?

Novo Nordisk Foundation Cellerator focuses on Cell Therapy, Regenerative Medicine, Biotechnology, Pharmaceuticals.

Comments

No comments yet. Be the first to share your take.